Home 2024
Archives
Co-construction: A key to preventing mental health injuries in occupational settings
Dr Mélanie Dufour-Poirier from the Université de Montréal and Dr Jean-Paul Dautel from the Université du Québec en Outaouais outline a new approach to preventing workplace mental health injuries and improving wellbeing.
The risk of malignant pleural mesothelioma
Although the use of asbestos-containing building materials was banned in the UK in 1999, this carcinogenic mineral continues to be a serious health threat. Daniel J. Murphy from the University of Glasgow tells us more.
Artificial intelligence (AI) tools in genetics
Vessela Kristensen and Dag Undlien uncover AI tools in genetics, from variant recognition to clinical implementation.
Can the arts be an effective tool to combat psychosis stigma?
There has been a rise in stigma for mental illnesses over the past few decades, particularly for psychotic symptoms. However, artistic representation may be the key to eliminating psychosis stigma.
The future of AVS, dizziness, and vertigo in emergency departments: Part II. Policy innovations...
In the second article of this five-part series, Dr Millie Nakatsuka discusses the barriers that contribute to the overuse of neuroimaging associated with the diagnosis of acute vestibular syndrome and proposes systemic reform.
The European REVERT Project: An ai-based dss for treatment selection
Find out here about the European REVERT project, an AI-based DSS for treatment selection.
Hearing and auditory research for cochlear implant outcomes
Amit Walia, Matthew Shew, and Craig A Buchman from Washington University School of Medicine, guide us through hearing and auditory research predictive models for cochlear implant outcomes in adults.
Investigating lung cancer using genetically engineered mouse models (GEMMS)
Daniel J. Murphy, Professor of Lung Cancer & Mesothelioma at the University of Glasgow, School of Cancer Sciences, discusses opportunities for improving cancer research and care through the use of genetically engineered mouse models.
The opioid crisis in canada – Governmental responses and strategies
Norm Buckley, Scientific Director at the Michael G. DeGroote Institute for Pain Research & Care, and Jason Busse, Director of the Michael G DeGroote National Pain Centre at McMaster University, discuss the complexities of chronic pain management and addressing the opioid crisis.
Why greener pharmaceutical manufacturing is vital for the industry and our health
Determined to tackle the carbon footprint of medicine, CPI’s Medicines Manufacturing Innovation Centre is addressing key sustainability issues in pharmaceutical manufacturing.
Upscaling integrated mental health services and systems for people of forced migration
How can realist impact evaluation be used to upscale the integration of mental health programs for people of forced migration? Nancy Clark, an Associate Professor from the University of Victoria, investigates.
Are nanotextures enough to kill cancer cells?
Nanotextures on nanoparticles and implants to kill cancer cells in a more targeted manner may just be the key to tackling resistance to traditional cancer drugs.
Meal replacements: An educational tool for weight reduction in patients with diabetes in rural...
Richard J Santen, Emeritus Professor of Medicine at the University of Virginia, discusses how meal replacements can aid successful weight loss for individuals with diabetes living in rural, underserved communities.
Delivering the best policy for cancer patients: Follow the science – follow the data
Mark Lawler, from the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast, reflects on key milestones in cancer policy initiatives and how data support innovative cancer research, optimal care and equity of access.
Invasive electrical stimulation for stroke treatment
The CorTec Brain Interchange system is a potential tool to improve motor rehabilitation after stroke (Schuettler, 2023). Here, it is sketched how results from studies of other groups are combined to form CorTec’s vision of a new therapy and how first human data was collected to prove the systems therapy capability.
Development of novel therapies for pediatric cancer: Successes and challenges
Peter J. Houghton from Greehey Children’s Cancer Research Institute and Mary-Ann Bjornsti from the University of Alabama discuss some of the key challenges in the development of therapies for pediatric cancer care.
Tackling physical inactivity and a sedentary lifestyle: Two distinct approaches
Being physically inactive and sedentary are two distinct issues that affect older adults. However, each problem necessitates a unique set of solutions; Professor Isabelle J. Dionne from the Université de Sherbrooke tells us more.
Therapeutic potential of the endocannabinoid system to treat chronic pain in inflammatory disease
Pharma researchers Julie Blaising and Philip Smith from F. Hoffmann-La Roche Ltd. discuss the endocannabinoid system as a pathway to treat inflammatory diseases such as Inflammatory Bowel Disease (IBD) and endometriosis.
Flame system: Computerised cognitive assessment for remote brain health monitoring
Monitoring brain health, particularly cognition, in older adults is increasingly recognised as a significant priority for research, healthcare and broader public health. Find out here about the development and validation of the FLAME System, a computerised cognitive assessment for remote brain health monitoring.
Medical abrasion phenomenon as a cause of knee osteoarthritis
Professor Shaw-Ruey Lyu from Tzu-Chi University tells us how the discovery of the medial abrasion phenomenon, as a cause of knee osteoarthritis, has changed how it is best treated.